Cytosorbents (CTSO) Total Debt Growth (3y) (2019 - 2026)
Cytosorbents (CTSO) Total Debt Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -13.48% |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 50.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.86% |
| Mar 31, 2026 | 50.14% |
| Dec 31, 2025 | 49.38% |
| Sep 30, 2023 | -30.76% |
| Jun 30, 2023 | -38.69% |
| Mar 31, 2023 | -30.75% |
| Dec 31, 2022 | -30.74% |
| Sep 30, 2020 | 5.35% |
| Jun 30, 2020 | 29.90% |
| Mar 31, 2020 | 34.68% |
| Dec 31, 2019 | 45.25% |
| Sep 30, 2019 | -13.12% |
| Jun 30, 2019 | 25.94% |